Valeant says it began shipping authorized generic version of irritable bowel drug Librax
Valeant Pharma begins selling generic IBS drug
ALISO VIEJO, Calif. — Valeant Pharmaceuticals said Monday it began selling a generic version of Librax, a treatment for irritable bowel syndrome drug.
Valeant said its product is an authorized generic. It will be sold by Valeant’s Oceanside Pharmaceuticals division. Librax is a combination of two compounds: chlordiazepoxide hydrochloride, and … Read more : Valeant says it began shipping authorized generic version of irritable bowel drug Librax. Go to Source
People who read this also read
- Irritable Bowel Syndrome Does Not Respond To St. John’s Wort
A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). Whi... - St. John’s Wort Not Helpful Treatment For Irritable Bowel Syndrome
A Mayo Clinic research study published in the January issue of The American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). Whi... - A Survey Into The Current Situation Of Britain’s Irritable Bowel Syndrome
A survey into the current situation of Britain's Irritable Bowel Syndrome (IBS) sufferers has thrown up an unexpected and worrying finding about a condition that affects one in five people.
Go to So... - Lexicon Pharma says its irritable bowel syndrome drug LX1031 met study goal; shares jump
Lexicon says IBS drug met mid-stage study goal
THE WOODLANDS, Texas — Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial.
... - Constipation in Children Causes, Symptoms, Diagnosis, Treatment,
Constipation occurs commonly in children, affecting up to 10% at any given time. Still, only 3% of parents actually seek advice from the doctor for this condition. Constipation describes the infrequen... - ‘Junk DNA’ Could Spotlight Breast And Bowel Cancer
Cancer Research UK funded scientists have found that a group of rogue genetic messengers, produced by DNA sequences commonly known as 'junk DNA', could help diagnose breast and bowel cancer. Their res... - Inflammatory Mediator Regulates Diarrhea In Inflammatory Bowel Disease
Researchers led by Dr. Terrence A. Barrett of Northwestern University Medical School in Chicago. Illinois have discovered that activation of NK-κB, an inflammatory mediator, results in diarrhea in in... - Anal fissure and fistula – fissures symptoms, treatment and healing
An anal fissure is a tear in the skin around the opening of the anus. It can cause sharp pain, especially when opening the bowels. Anal fissure is thought to be a common disorder for which many people... - H1N1 Cases Still Increasing In Many Countries; WHO To Begin Shipping Donated Vaccines Within Weeks
With many countries continuing to report a growing number of H1N1 (swine flu) cases, Keiji Fukuda, special adviser to the WHO director general on pandemic influenza, said Thursday it was too early to ... - Breakthrough On Causes Of Inflammatory Bowel Disease
New research by the University of Adelaide could help explain why some people are more prone to Crohn's disease, ulcerative colitis and other autoimmune diseases. A critical imbalance of the regulato...
